Implications for Clinical Practice The study demonstrates the importance of managing comorbid metabolic conditions in patients with HS, not only for overall health but also for potential benefits in disease management
It randomised 156 participants with early disease to daily subcutaneous lixisenatide or placebo for 12 months, followed by a 2-month washout
Ngoi ra, tnh trng thm sm, l chn lng to cng khin nhiu ch em rt au u
"I just don't think a body should ever be a trend." The prevalence of GLP-1 medications has changed the game in a lot of ways
We want to help your body make more GLP-1s naturally, instead of forcing a particular result
Examples include allopurinol, atenolol, captopril, carbamazepine, cephalosporins, gold, hydralazine, penicillin, phenytoin, primidone, pyrimethamine, quinidine, sulfonamides, and sulindac